Yi Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yi Gao has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Lu Chen
Department of Urinary Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
3 shared publications- Dan-Feng Xu
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications Fa-Jun Qu
Department of Urinary Surgery, Third Affiliated Hospital, Second Military Medical University, Shanghai 201805, China
2 shared publicationsHai Huang
Department of Urinary Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
2 shared publicationsJian-Min Lv
Department of Urinary Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
2 shared publicationsLin Li
Department of Urinary Surgery, Third Affiliated Hospital, Second Military Medical University, Shanghai 201805, China
2 shared publications
Latest Publications
- Open Access
- 18 September 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (58) , 98117-98134
High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer
High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer
- 18 September 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (58) , 98117-98134
Open AccessHigh expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer
High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer
- Open Access
- 8 September 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (45) , 78989-79002
Frizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma
Frizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma Frizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma
- 8 September 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (45) , 78989-79002
Open AccessFrizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma
Frizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma Frizzled 8 promotes the cell proliferation and metastasis of renal cell carcinoma
- Open Access
- 16 May 2017
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 51 (1) , 39-48
Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells
Serine/threonine protein phosphatase 5 (PPP5C) is a member of the protein serine/threonine phosphatase family and has been shown to participate in multiple signaling cascades and tumor progression. We found that PPP5C was highly expressed in bladder cancer tissues compared to normal urothelial tissues, and positively correlated to tumor stages through ONCOMINE microarray data mining. Knockdown of PPP5C via a lentivirus-mediated short hairpin RNA (shRNA) markedly inhibited cell proliferation and colony formation. Flow cytometric analysis showed that PPP5C-deficient T24 and BT5637 bladder cancer cells were arrested in G0/G1 phase and induced apoptosis. In addition, tumor growth was inhibited in vivo in a xenograft nude mouse model. Further studies indicated that knockdown of PPP5C downregulated c-myc and CDK4, whereas upregulated p27, BAD and Beclin1. These results suggest that PPP5C is associated with bladder cancer (BCa) and plays an oncogenic role in the development and progression of bladder cancer.
- 16 May 2017
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 51 (1) , 39-48
Open AccessDisruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells
Serine/threonine protein phosphatase 5 (PPP5C) is a member of the protein serine/threonine phosphatase family and has been shown to participate in multiple signaling cascades and tumor progression. We found that PPP5C was highly expressed in bladder cancer tissues compared to normal urothelial tissues, and positively correlated to tumor stages through ONCOMINE microarray data mining. Knockdown of PPP5C via a lentivirus-mediated short hairpin RNA (shRNA) markedly inhibited cell proliferation and colony formation. Flow cytometric analysis showed that PPP5C-deficient T24 and BT5637 bladder cancer cells were arrested in G0/G1 phase and induced apoptosis. In addition, tumor growth was inhibited in vivo in a xenograft nude mouse model. Further studies indicated that knockdown of PPP5C downregulated c-myc and CDK4, whereas upregulated p27, BAD and Beclin1. These results suggest that PPP5C is associated with bladder cancer (BCa) and plays an oncogenic role in the development and progression of bladder cancer.